Correspondence

Response to the ACMD on GHB, GBL and closely related compounds

The government responds to the Advisory Council on the Misuse of Drugs on its assessment of the harms of GHB and GBL.

This was published under the 2019 to 2022 Johnson Conservative government

Documents

Letter from the Minister of State for Crime, Policing and Probation to the Chair of the Advisory Council on the Misuse of Drugs

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Letter from the Home Secretary to the Chair of the Advisory Council on the Misuse of Drugs

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

These letters from the government are in response to the assessment provided by the Advisory Council on the Misuse of Drugs (ACMD) of the harms of gamma-hydroxybutyric acid, gamma-butyrolactone, and closely related compounds.

Updates to this page

Published 30 March 2021
Last updated 27 April 2022 + show all updates
  1. Added further government response to ACMD's report - 'Letter from the Minister of State for Crime, Policing and Probation to the Chair of the Advisory Council on the Misuse of Drugs'.

  2. First published.

Sign up for emails or print this page